ALEXANDRIA, Va., June 5 -- United States Patent no. 12,274,753, issued on April 15, was assigned to VERVE THERAPEUTICS INC. (Boston).
"Compositions and methods for targeted RNA delivery" was invented by Kallanthottathil G. Rajeev (Wayland, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compositions, methods of making the same, and methods for targeted delivery of therapeutic agents for modifying expression and function of target genes, e.g. proteins involved in lipid and cholesterol metabolism such as PCSK9. Further provided herein are compositions and methods of treating conditions related to coronary disease."
The patent was filed on Sept. 19, 2023, under Application No. 18/470,2...